ETFChannel.com
Invesco S&P Ultra Dividend Revenue ETF

Fund Name:
Invesco S&P Ultra Dividend Revenue ETF
Issuer:
Invesco
Total Net Assets:
$763,012,620
Inception:
09/30/2013
Related Index:
REVWDIVT
ETF Category: 
Income
Expense Ratio: 
0.39% 
Net Asset Value: 
$40.63  
Number of Holdings: 
62  
Annualized Yield: 
3.44%  
Annualized Distribution: 
1.396  
RDIV Dividend History » 
Stock Weight Amount
Merck & Co. 5.94% $45,295,748
Pfizer 5.70% $43,506,939
Gilead Sciences 5.43% $41,396,695
Abbvie 5.28% $40,274,285
Walgreens Boots Alliance 4.92% $37,510,374
List of all 62 stocks held by RDIV »
Quotes delayed 20 minutes

Email EnvelopeFree RDIV Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Hold (2.47 out of 4)
0th percentile
(ranked lower than approx. 100% of all etfs covered)
Based on data provided by Zacks Investment Research via Quandl.com
Shares Short 37,662
Chg. from Last Month +14,412
Shares Outstanding 18,780,000
% of Shares Short 0.20%
Days to Cover 0.6
Based on third party short interest data.

RDIV | Invesco S&P Ultra Dividend Revenue ETF | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2022, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.